Table 3.
Summary of pharmacological data
Glutamate EC50, μM (n) | Glycine EC50, μM (n) | %, pH6.8/pH7.6γ | |
---|---|---|---|
WT GluN1/WT 2A | 4.9 ± 0.35 (26) | 1.1 ± 0.06 (23) | 44 ± 1.8 (29) |
1-G618R/2A | 4.8 ± 0.28 (10) | 1.7 ± 0.07 (9)* | 38 ± 3.1 (12) |
1-G620R/2A | 6.2 ± 0.42 (11) | 1.3 ± 0.10 (12) | 25 ± 1.8 (10)* |
2A-L611Q | 2.5 ± 0.16 (21)* | 0.83 ± 0.08 (16)* | 63 ± 2.3 (11)* |
2A-N614S | 2.6 ± 0.38 (11)* | 0.61 ± 0.03 (11)* | 57 ± 2.8 (12)* |
2A-N615K | 2.8 ± 0.23 (12)* | 0.75 ± 0.08 (13)* | 44 ± 1.8 (10) |
WT GluN1/WT 2B | 1.5 ± 0.09 (25) | 0.43 ± 0.04 (40) | 17 ± 0.7 (31) |
1-G618R/2B | 1.3 ± 0.10 (12) | n.a. | 21 ± 1.4 (15)* |
1-G620R/2B | 1.9 ± 0.22 (12) | 0.43 ± 0.03 (9) | 18 ± 1.2 (10) |
2B-W607C | 2.0 ± 0.22 (12)* | 0.44 ± 0.05 (10) | 11 ± 0.70 (12)* |
2B-G611V | 1.7 ± 0.33 (12) | 0.28 ± 0.04 (8) | 12 ± 2.0 (10) |
2B-N615I | 1.4 ± 0.16 (10) | 0.26 ± 0.02 (11)* | 19 ± 0.6 (6) |
2B-N615K | 1.3 ± 0.16 (11) | 0.22 ± 0.03 (12)* | 16 ± 3.8 (7) |
2B-N616K | 1.1 ± 0.19 (8) | 0.14 ± 0.01 (7)* | 17 ± 1.7 (12) |
2B-V618G | 1.6 ± 0.15 (8) | 0.47 ± 0.02 (15) | 10 ± 0.68 (10)* |
2B-V620M | 1.1 ± 0.11 (12) | 0.58 ± 0.07 (21) | 24 ± 1.8 (10)* |
Data were generated by oocytes recordings with −40 mV of holding potential, and were expressed as Mean ± SEM (n).
percentage of the current at pH 6.8 compared to that at pH 7.6.
p < 0.05 LogEC50 compared by one way ANOVA, with Dunnett’s multiple comparisons test.
Statistical analysis is given in Supp. Table S2.